Creutzfeldt-Jakob disease via dural and corneal transplants

Journal of the Neurological Sciences

Volumn 160, Issue 2, 1998, Pages 128-139

  Lang, C J G ^a   Heckmann, J G ^a   Neundorfer B ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cornea; Creutzfeldt Jakob disease; Dementia; Dura mater; Iatrogenic transmission; Transplantation

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CORNEA TRANSPLANTATION; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DISEASE TRANSMISSION; DURA MATER; FEMALE; HORMONAL THERAPY; HUMAN; IATROGENIC DISEASE; INJECTION; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0032497692     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00226-3     Document Type: Review

References (95)

1. Allan B., Tuft S. Transmission of Creutzfeldt-Jakob disease in corneal grafts. Br Med J. 315:1997;1553-1554.
2. Antoine J.C., Michel D., Bertholon P.et al. Creutzfeldt-Jakob disease after extracranial dura mater embolization for a nasopharyngeal angiofibroma. Neurology. 48:1997;1451-1453.
3. Bell JE. Neuropathological diagnosis of human prion disease. In: Baker H, Ridley RM, editors. Methods in molecular medicine: Prion diseases. Totowa: Humana Press, 1996:59-83.
4. Billette de Villemeur T., Deslys J.-P.et al. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology. 47:1996;690-695.
5. Brown P. Can Creutzfeldt-Jakob disease be transmitted by transfusion? Curr Opin Hematol. 2:1995;472-477.
6. Brown P. Environmental causes of human spongiform encephalopathy. In: Baker H, Ridley RM, editors. Methods in molecular medicine: Prion diseases. Totowa: Humana Press, 1996:139-54.
7. Brown P., Cervenáková L., Goldfarb L.G.et al. Iatrogenic Creutzfeldt-Jakob disease: An example of the interplay between ancient genes and modern medicine. Neurology. 44:1994;291-293.
8. Brown P., Gibbs C.J. Jr., Rodgers-Johnson P.et al. Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol. 35:1994;513-529.
9. Brown P., Preece M.A., Will R.G. "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet. 340:1992;24-27.
10. Budka H., Aguzzi A., Brown P.et al. Konsensusbericht: Gewebsbehandlung bei Verdacht auf Creutzfeldt-Jakob-Krankheit und andere spongiforme Enzephalopathien (Prionen-Krankheiten) des Menschen. Pathologe. 17:1996;171-176.
11. Chazot G., Broussolle E., Lapras C.I., Blättler T., Aguzzi A., Kopp N. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet. 347:1996;1181.
12. Clavel M., Clavel P. Creutzfeldt-Jakob disease transmitted by dura mater graft. Eur Neurol. 36:1996;239-240.
13. Collinge J, Palmer MS. Human prion diseases. In: Collinge J, Palmer MS, editors. Prion diseases. Oxford: Oxford University Press, 1997:18-56.
14. Collins S, Fletcher A, De Luise T, Boyd A, Masters CL. Creutzfeldt-Jakob disease in Australia. In: Court L, Dodet B, editors. Transmissible subacute spongiform encephalopathies. Paris: Elsevier, 1996:405-15.
15. Collins S., Masters C.L. Iatrogenic and zoonotic Creutzfeldt-Jakob disease: the Australian perspective. Med J Austral. 164:1996;598-602.
16. Court L, Dodet B, editors. Transmissible subacute spongiform encephalopathies - Prion diseases. Paris: Elsevier, 1996.
17. Davanipour Z., Alter M., Sobel E., Asher D., Gajdusek D.C. Creutzfeldt-Jakob disease: possible medical risk factors. Neurology. 35:1985;1483-1486.
18. Defebvre L., Destée A., Caron J., Ruchoux M.M., Wurtz A., Remy J. Creutzfeldt-Jakob disease after an embolization of intercostal arteries with cadaveric dura mater suggesting a systemic transmission of the prion agent. Neurology. 48:1997;1470-1471.
19. Delasnerie-Lauprêtre N. Epidemiology of Creutzfeldt-Jakob disease in France. In: Court L, Dodet B, editors. Transmissible subacute spongiform encephalopathies. Paris: Elsevier, 1996:395-98.
20. Deslys J.-P., Lasmézas C.I., Streichenberger N.et al. New variant Creutzfeldt-Jakob disease in France. Lancet. 349:1997;30-31.
21. Diringer H. Letter to the editor. Lancet. 347:1996;1332-1333.
22. Diringer H, Braig HR. Infectivity of unconventional viruses in dura mater. Lancet 1989;439-440.
23. Dormont D. How to limit the spread of Creutzfeldt-Jakob disease. Infect Control Hosp Epidemiol. 17:1996;521-528.
24. Dormont D. Creutzfeldt-Jakob disease and transplantation: facts and fables. Transplant Proceed. 28:1996;2931-2933.
25. Duffy P., Wolf J., Collins G., DeVoe A.G., Streeten B., Cowen D. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med. 290:1974;692-693.
26. Esmonde T., Lueck C.J., Symon L., Duchen L.W., Will R.G. Creutzfeldt-Jakob disease and lyophilised dura mater grafts: report of two cases. J Neurol Neurosurg Psychiatry. 56:1993;999-1000.
27. Esmonde T.F.G., Will R.G., Slattery J.M.et al. Creutzfeldt-Jakob disease and blood transfusion. Lancet. 341:1993;205-207.
28. Evers S., Droste D.W., Lüdemann P., Oberwitter C. Early elevation of cerebrospinal fluid neuron-specific enolase in Creutzfeldt-Jakob disease. J Neurol. 245:1998;52-53.
29. Hainfellner J.A., Jellinger K., Diringer H.et al. Die Creutzfeldt-Jakob-Krankheit in Österreich. Wien Klin Wochenschr. 108:1996;759-763.
30. Heckmann J.G., Lang C.J.G., Petruch F.et al. Transmission of Creutzfeldt-Jakob disease via a corneal transplant. J Neurol Neurosurg Psychiatry. 63:1997;388-390.
31. Ironside J.W., Bell J.E. Florid plaques and new variant Creutzfeldt-Jakob disease. Lancet. 350:1997;1475.
32. Ironside JW, Sutherland K, Bell JE, et al. A new variant of Creutzfeldt-Jakob disease: Neuropathological and clinical features. Cold Spring Harbour Symposia on Quantitative Biology, vol. 61. Cold Spring Harbour: Cold Spring Harbour Laboratory Press, 1996:523-30.
33. Janssen R.S., Schonberger B. Creutzfeldt-Jakob disease from allogenic dura: a review of ist risks and safety. J Oral Maxillofac Surg. 49:1991;274-275.
34. Kniekamp H.-E. Safety of Lyodura. J Oral Maxillofac Surg. 52:1994;896.
35. Kondo K. Epidemiology of human prion diseases. Nippon Rinsho. 55:1997;978-986. In Japanese.
36. Kopp N., Streichenberger N., Deslys J.P., Laplanche J.L., Chazot G. Creutzfeldt-Jakob disease in a 52-year-old woman with florid plaques. Lancet. 348:1996;1239-1240.
37. Kretzschmar H.A., Ironside J.W., DeArmond S.J., Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol. 53:1996;913-920.
38. Lane K.L., Brown P., Howell D.N.et al. Creutzfeldt-Jakob disease in a pregnant woman with an implanted dura mater graft. Neurosurgery. 34:1994;737-740.
39. Lang C.J., Schüler P., Engelhardt A., Spring A., Brown P. Probable Creutzfeldt-Jakob disease after a cadaveric dural graft. Eur J Epidemiol. 11:1995;79-81.
40. Liou H.-H., Jeng J.-S., Chang Y.-C., Chen R.-C., Yip P.-K. Is ataxic gait the predominant presenting manifestation of Creutzfeldt-Jakob disease? Experience from 14 Chinese cases from Taiwan. J Neurol Sci. 140:1996;53-60.
41. Manuelidis L. Decontamination of Creutzfeldt-Jakob disease and other transmissible agents. J Neuro Virology. 3:1997;62-65.
42. Manuelidis E.E., Angelo J.N., Gorgaz E.J., Kim J.H., Manuelidis L. Experimental Creutzfeldt-Jakob disease transmitted via the eye with infected cornea. N Engl J Med. 296:1977;1334-1336.
43. Martínez-Lage JF, Poza M. Iatrogenic Creutzfeldt-Jakob disease acquired after neurosurgery and dura mater grafts. In: Court L, Dodet B, editors. Transmissible subacute spongiform encephalopathies: Prion Diseases. Paris: Elsevier, 1996:459-464.
44. Martínez-Lage J.F., Poza M., Sola J.et al. Accidental transmission of Creutzfeldt-Jakob disease by dural cadaveric grafts. J Neurol Neurosurg Psychiatry. 57:1994;1091-1094.
45. Martínez-Lage J.F., Poza M., Tortosa J.G. Creutzfeldt-Jakob disease in patients who received a cadaveric dura mater graft - Spain, 1985-1992. MMWR. 42:1993;560-563.
46. Martínez-Lage J.F., Sola J., Poza M., Esteban J.A. Pediatric Creutzfeldt-Jakob disease: probable transmission by a dural graft. Child's Nerv Syst. 9:1993;239-242.
47. Mastrianni J.A., Curtis M.T., Oberholtzer J.C.et al. Prion disease (PrP-A117V) presenting with ataxia instead of dementia. Neurology. 45:1995;2042-2050.
48. Masters C.L., Harris J.O., Gajdusek D.C., Gibbs C.J.J., Bernouilli C., Asher D.M. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 5:1979;177-188.
49. Masullo C., Pocchiari M., Macchi G., Alema G., Piazza G., Panzera M.A. Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. J Neurosurg. 71:1989;954-955.
50. Menache D., O'Malley J.P. Creutzfeldt-Jakob disease: Current U.S. policy to further reduce the possible risk of transmission by transfusion. Biologicals. 24:1996;277-283.
51. Miyashita K., Inuzuka T., Kondo H.et al. Creutzfeldt-Jakob disease in a patient with a cadaveric dural graft. Neurology. 41:1991;940-941.
52. Morris K. WHO reconsiders risks from Creutzfeldt-Jakob disease. Lancet. 349:1997;1001.
53. Nisbet T.J., MacDonaldson I., Bishara S.N. Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. MMWR. 38:1989;37-38.
54. Nisbet T.J., MacDonaldson I., Bishara S.N. Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. J Am Med Assoc. 261:1989;1118.
55. Otto D. Response [to Penar and Prichard 1987]. J Neurosurg. 67:1987;149-150.
56. Otto M., Stein H., Szudra A.et al. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol. 244:1997;566-570.
57. Otto M., Wiltfang J., Schütz E.et al. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. Br Med J. 316:1998;577-582.
58. Otto A., Zerr I., Lantsch M., Weidehaas K., Riedemann C., Poser S. Akinetic mutism as a classification criterion for the diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 64:1998;524-528.
59. Parchi P., Capellari S., Chen S.G.et al. Typing prion isoforms. Nature. 386:1997;232-233.
60. Parchi P., Castellani R., Capellari S.et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 39:1996;767-778.
61. Penar P.L., Prichard J.W. Jakob-Creutzfeldt disease associated with cadaveric dura. J Neurosurg. 67:1987;149.
62. Pocchiari M., Masullo C., Salvatore M., Genuardi M., Galgani S. Creutzfeldt-Jakob disease after non-commercial dura mater graft. Lancet. 340:1992;614-615.
63. Poser S., Zerr I., Schulz-Schaeffer W.J., Kretzschmar H.A., Felgenhauer K. Die Creutzfeldt-Jakob-Krankheit. Eine Sphinx der heutigen Neurobiologie. Dt Med Wochenschr. 122:1997;1099-1105.
64. Prichard J., Thadani V., Kalb R., Manuelidis E., Hadler J. Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. MMWR. 34:1987;49-55.
65. Prichard J.W. Response [to Masullo et al. 1989]. J Neurosurg. 71:1989;955.
66. Ridley R.M., Baker H.F. Occupational risk of Creutzfeldt-Jakob disease. Lancet. 341:1993;641-642.
67. Rohwer RG. The management of risk from exposure of biomedical products to the spongiform encephalopathy agent(s). In: Court L, Dodet B, editors. Transmissible subacute spongiform encephalopathies. Paris: Elsevier, 1996:471-78.
68. Rosenmann H., Meiner Z., Kahana E.et al. Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease. Neurology. 49:1997;593-595.
69. Sato T., Hoshi K., Yoshino H., Urata J., Nakamura Y., Yanagawa H. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts - Japan, January 1979-May 1996. MMWR. 46:1997;1066-1069.
70. Sato T., Hoshi K., Yoshino H., Urata J., Nakamura Y., Yanagawa H. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts - Japan, January 1979-May 1996. J Am Med Assoc. 279:1998;11-12.
71. Stratton E. Creutzfeldt-Jakob disease: the Canadian situation. Can Med Assoc J. 157:1997;1405-1406.
72. Stratton E., Rickets M.N., Gully P.R. The epidemiology of Creutzfeldt-Jakob disease in Canada: a review of mortality data. Emerg Infect Diseases. 3:1997;63-64.
73. Takashima S., Tateishi J., Taguchi Y.et al. Creutzfeldt-Jakob disease with a widespread presence of kuru-type plaques after cadaveric dural graft replacement - An autopsy case. Rinsho Shinkeigaku. 37:1997;824-828. In Japanese.
74. Takashima S., Tateishi J., Taguchi Y., Inoue H. Creutzfeldt-Jakob disease with florid plaques after cadaveric dural graft in a Japanese woman. Lancet. 350:1997;865-866.
75. Takayama S., Hatsuda N., Matsumura K., Nakasu S., Handa J. Creutzfeldt-Jakob disease transmitted by cadaveric dural graft: a case report. No Shinkei Geka. 21:1993;167-170. In Japanese.
76. Tateishi J., Kitamoto T., Hoque M.Z., Furukawa H. Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Neurology. 46:1996;532-537.
77. Taylor D.M. Letter in response to van Asten et al., 1996. Lancet. 347:1996;1333.
78. Taylor DM, Transmissible subacute spongiform encephalopathies: practical aspects of agent inactivation. In: Court L, Dodet B, editors. Transmissible subacute spongiform encephalopathies: Prion Diseases. Paris: Elsevier, 1996:479-82.
79. Taylor D.M., McConnell I. Unconventional transmissible agents in dura mater: significance for iatrogenic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol. 22:1996;259-260.
80. Thadani V., Penar P., Partington J.et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. J Neurosurg. 69:1988;766-769.
81. Uchiyama S., Ishida C., Yago S., Kurumaya H., Kitamoto T. An autopsy case of Creutzfeldt-Jakob disease associated with corneal transplantation. Dementia (Japan). 8:1994;466-473. In Japanese.
82. Villforth J.C. Dear Doctor. J Neurosurg. 67:1987;150.
83. Weber T., Tumani H., Holdorff B.et al. Transmission of Creutzfeldt-Jakob disease by handling of dura mater. Lancet. 341:1993;123-124.
84. Weber T., Otto M., Bodemer M., Zerr I. Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies. Biomed Pharmacother. 51:1997;381-387.
85. Weber T., Zerr I., Bodemer M., Poser S. Erweitertes Krankheitsspektrum humaner spongiformer Enzephalopathien oder Prionkrankheiten. Nervenarzt. 68:1997;309-323.
86. WHO. Public health issues and clinical and neurological characteristics of the new variant of Creutzfeldt-Jakob disease and other human and animal transmissible spongiform encephalopathies: Memorandum from two WHO meetings. Bull World Health Organisation 1996;74:453-63.
87. WHO. Fact sheet No 180, October 1997. Geneva, Switzerland, 1997.
88. WHO. Press release WHO/27, 27 March 1997. Geneva, Switzerland, 1997.
89. Will RG. Surveillance of prion diseases in humans. In: Baker H, Ridley RM, editors. Methods in molecular medicine: Prion diseases. Totowa: Humana Press, 1996:119-37.
90. Will R.G., Ironside J.W., Zeidler M.et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 347:1996;921-925.
91. Willison H.J., Gale A.N., McLaughlin J.E. Creutzfeldt-Jacob (sic) disease following cadaveric dura mater graft. J Neurol Neurosurg Psychiatry. 54:1991;940.
92. Yamada S., Aiba T., Endo Y., Hara M., Kitamoto T., Tateishi J. Creutzfeldt-Jakob disease transmitted by a cadaveric dura mater graft. Neurosurgery. 34:1994;740-744.
93. Yamada M., Itoh Y., Suematsu N., Matsushita M., Otomo E. Panencephalopathic type of Creutzfeldt-Jakob disease associated with cadaveric dura mater graft. J Neurol Neurosurg Psychiatry. 63:1997;524-527.
94. Zeidler M., Stewart G.E., Barraclough C.R.et al. New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet. 350:1997;903-907.
95. Zerr I., Bodemer M., Gefeller O.et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 43:1998;32-40.